Basilea Pharmaceutica AG
BPMUF
$54.00
$1.172.22%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.56M | 44.11M | -861.60K | 5.38M | 10.73M |
| Total Depreciation and Amortization | 3.69M | 3.69M | 3.67M | 3.63M | 3.57M |
| Total Amortization of Deferred Charges | 1.02M | 1.34M | 1.65M | 1.81M | 1.95M |
| Total Other Non-Cash Items | -15.44M | -12.85M | -10.23M | -3.43M | 3.54M |
| Change in Net Operating Assets | 7.08M | 12.19M | 17.31M | 6.40M | -4.42M |
| Cash from Operations | 84.92M | 48.48M | 11.54M | 13.79M | 15.36M |
| Capital Expenditure | -1.95M | -1.53M | -1.09M | -1.01M | -908.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 878.40K | 878.40K | 878.40K | 446.60K | -- |
| Other Investing Activities | -92.90K | -158.80K | -224.70K | -237.10K | -247.30K |
| Cash from Investing | -1.17M | -805.90K | -435.70K | -796.40K | -1.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.60M | -36.05M | -56.49M | -57.90M | -59.31M |
| Issuance of Common Stock | 2.46M | 2.91M | 3.36M | 2.92M | 2.48M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.00K | -128.50K | -236.00K | -354.00K | -472.00K |
| Cash from Financing | -14.81M | -37.51M | -60.26M | -62.50M | -64.22M |
| Foreign Exchange rate Adjustments | 54.90K | 10.00K | -34.60K | -101.60K | -170.40K |
| Miscellaneous Cash Flow Adjustments | -- | -600.00 | -1.20K | -600.00 | -100.00 |
| Net Change in Cash | 69.00M | 10.18M | -49.20M | -49.60M | -50.18M |
